Machado-Joseph disease/spinocerebellar ataxia-3 (MJD/SCA
INTRODUCTION
Since the pathological change of spinal and bulbar muscular atrophy (SBMA) has been found to be due to the expansion of the CAG repeat in the androgen receptor gene (Spada et al., 1991) , an increasing number of hereditary neurodegenerative disorders have been found to be caused by CAG expansion that encodes an expanded polyglutamine stretch in distinst proteins (Paulson, 1999) . These disorders are now characterized as polyglutamine diseases and have been found to possess unique pathological features such as neuronal intranuclear inclusion and selective neuronal death, suggesting the presence of common pathological processes (Kakizuka, 1998; Perutz, 1999) .
Machado-Joseph disease (MJD/spinocerebellar ataxia type 3; SCA3) is an autosomal dominant spinocerebellar ataxia that belongs to a polyglutamine disease (Kawaguchi et al., 1994) . The protein coded by MJD cDNA, ataxin-3, contains a polyglutamine stretch and its expansion produces neuronal cell death. In vitro cellular models and transgenic animals have been created and analyzed with the truncated ataxin-3 with an expanded polyglutamine stretch, in which polyglutamine-containing aggregates and cell death were invariably observed (Ikeda et al., 1996; Paulson et al., 1997; Jackson et al., 1998;  
